Stay updated with breaking news from Omnipod System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet Co. (NASDAQ:PODD – Free Report) – Research analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Insulet in a research note issued to investors on Friday, February 23rd. Leerink Partnrs analyst M. Kratky anticipates that the medical instruments supplier will post earnings per share of $7.84 for the year. […]
Insulet Co. (NASDAQ:PODD – Free Report) – Analysts at William Blair raised their Q1 2024 earnings per share (EPS) estimates for shares of Insulet in a research report issued on Friday, February 23rd. William Blair analyst M. Kaczor now forecasts that the medical instruments supplier will earn $0.43 per share for the quarter, up from […]
Sherbrooke Park Advisers LLC bought a new stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 10,107 shares of the medical instruments supplier’s stock, valued at approximately $1,612,000. Other institutional investors have […]
Sherbrooke Park Advisers LLC bought a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 3rd quarter, Holdings Channel reports. The institutional investor bought 10,107 shares of the medical instruments supplier’s stock, valued at approximately $1,612,000. Several other institutional investors and hedge funds also recently made changes to their positions in the company. […]
Insulet (NASDAQ:PODD – Free Report) had its price objective cut by Piper Sandler from $250.00 to $230.00 in a report published on Friday, Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. Several other brokerages have also recently weighed in on PODD. Morgan Stanley raised Insulet from an equal weight […]